23andMe, Pfizer launch Lupus Research Study jointly 23andMe, Inc cialis eu ., the leading personal genetics company, today announced the start of the Lupus STUDY in collaboration with Pfizer Inc. The ongoing companies try to enroll 5,000 individuals with systemic lupus erythematosus, even more referred to as lupus commonly, into the study to help better understand the genetics of lupus. The effort is also in collaboration with the Lupus Research Institute, and in collaboration with Lupus Consciousness Month in May. Approximately 1.5 million people in the U.S. Suffer from lupus, an autoimmune disease in which the immune system can attack the normal, healthy tissues of your body almost anywhere. Some of the more common symptoms include joint inflammation, skin rashes and sores, along with kidney, heart, and lung damage.
The three task orders had been awarded to: IT Solutions provides the design and execution and also migration of existing FDA applications to the recently configured White colored Oak Data Center, which will support all FDA development and test applications. Buccaneer supplies the functions and maintenance of the White Oak Data Middle. EDS provides the design, execution, migration and procedures and maintenance of existing FDA applications to a Contractor Owned Contractor Operated hosted data center for FDA production functions. All FDA applications and hosting procedures shall transition to the new data centers over a two-year period. The resulting enhanced computing power and greater responsiveness will provide the FDA with the various tools it needs to ensure that all products reaching the American public are safer and far better..